The INTRICATE program has brought forward a strategic platform technology to develop assets in the field of rheumatology, orthopedics and tissue engineering. The development strategy for INTRICATE is to advance multiple INTRICATE candidates across different selectivity profiles, and to test these in a broad panel of in vivo rheumatic and degenerative disease as well as traumatic models targeting a number of indications, with a key focus on tissue regeneration. 

Click here to know more